Swarnroop, a key pharmaceutical manufacturer based in Maharashtra, is actively involved in the synthesis of crucial Active Pharmaceutical Ingredients (APIs), notably Compound 188062-50-2. This effort is importantly aligned with essential AIDS research, supporting worldwide endeavors to address the pandemic. Their state-of-the-art infrastructure in